Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



sodium2 - intrauterine devices1 - gross hematuria1 - neuroendocrine prostate cancer1 - electromagnetic lithotripter1 - vitamin supplements1 - liver transplant1 - low-dose prednisone1 - autoimmune disease2 - prostate tissue1 - amgen1 - university of california san francisco and san francisco general hospital1 - pancreatic cancer2 - ifosfamide1 - cancer treatment3 - disease-related anemia1 - aids1 - pregnancy7 - nephrin1 - minimally invasive laparoscopic treatment of prostate cancer1 - malaise1 - lower urinary tract problems1 - microscopic nephrons1 - secondary tumor1 - prepucial stones1 - infertility2 - kidney removal1 - kidneys fail1 - fatty fish1 - posterior triangle1 -